INFY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Infosys Ltd (INFY) is not a strong buy at the moment for a long-term beginner investor with $50,000-$100,000 available. The stock exhibits mixed signals, with bearish technical indicators, declining financial performance, and cautious analyst sentiment. While recent acquisitions could potentially drive future growth, the immediate outlook does not justify a buy recommendation.
The technical indicators are mixed to bearish. The MACD is positive and expanding, indicating some bullish momentum, but the RSI is neutral at 38.462, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Support is at 12.713, and resistance is at 13.512. The stock has a 70% chance to decline in the short term (-1.49% in the next day, -3.16% in the next week, -9.95% in the next month).
Infosys has announced strategic acquisitions, including Stratus and Optimum Healthcare IT, to enhance digital transformation capabilities in the insurance and healthcare sectors. Hedge funds have significantly increased their buying activity, up 2577.23% over the last quarter.
Analyst sentiment is cautious, with recent downgrades and reduced price targets citing structural risks in the IT services sector due to AI-driven changes. Financial performance in Q3 2026 showed a decline in net income (-7.31% YoY), EPS (-5.26% YoY), and gross margin (-7.25% YoY).
In Q3 2026, revenue increased by 3.24% YoY to $5.1 billion, but net income dropped by 7.31% YoY to $747 million. EPS declined by 5.26% YoY to 0.18, and gross margin fell by 7.25% YoY to 28.28%.
Analysts have downgraded the stock to Hold, with price targets reduced by Jefferies ($14.31 from $20.82) and Stifel ($17 from $19). Analysts cite risks from AI-driven changes in the IT services business model. TD Cowen remains constructive on the sector but maintains a Hold rating with a price target of $17.
